These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6795915)

  • 81. Nitroglycerin and isosorbide dinitrate in pulmonary hypertension of chronic obstructive pulmonary disease.
    Delaunois L; Jonard P; Kremer N; Dubois P; Lulling J
    Bull Eur Physiopathol Respir; 1984; 20(1):11-8. PubMed ID: 6423015
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Haemodynamic effects of isosorbide dinitrate in patients with congestive cardiac failure at rest and during submaximal supine exercise.
    Stephens JD; Camm AJ; Spurrell RA
    Arch Mal Coeur Vaiss; 1978 Mar; 71(3):241-50. PubMed ID: 416797
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Haemodynamic comparison of different routes of nitrate administration in postmyocardial infarction left ventricular failure.
    Taylor SH; Verma SP; Silke B
    Z Kardiol; 1989; 78 Suppl 2():133-6; discussion 142-4. PubMed ID: 2511687
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Peripheral vasodilators in the treatment of heart failure].
    Serbin VI; Gasanova AS
    Pediatriia; 1982 Jan; (1):67-70. PubMed ID: 7038611
    [No Abstract]   [Full Text] [Related]  

  • 85. Increased intrapulmonary shunt following infusion of nitroglycerine or nitroprusside in patients with posttraumatic respiratory distress.
    Annest SJ; Rhodes GR; Stratton HH; Newell JC; Powers SR
    Surg Forum; 1979; 30():22-4. PubMed ID: 120015
    [No Abstract]   [Full Text] [Related]  

  • 86. Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure.
    Pouleur H; Covell JW; Ross J
    Circulation; 1980 Feb; 61(2):328-37. PubMed ID: 7351058
    [No Abstract]   [Full Text] [Related]  

  • 87. Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible.
    Horrow JC; Digregorio GJ; Barbieri EJ; Rupp E
    Crit Care Med; 1990 Aug; 18(8):858-61. PubMed ID: 2116261
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Combined infusion of nitroprusside and dobutamine in the treatment of severe congestive heart failure (author's transl)].
    Cyran J; Bolte HD
    Klin Wochenschr; 1979 Sep; 57(17):883-91. PubMed ID: 502356
    [No Abstract]   [Full Text] [Related]  

  • 89. Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
    Armstrong PW; Armstrong JA; Marks GS
    Circulation; 1980 Jul; 62(1):160-6. PubMed ID: 6769608
    [No Abstract]   [Full Text] [Related]  

  • 90. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.
    Franciosa JA; Goldsmith SR; Cohn JN
    Am J Med; 1980 Oct; 69(4):559-66. PubMed ID: 7424945
    [No Abstract]   [Full Text] [Related]  

  • 91. Loss of glyceryl trinitrate and of isosorbide dinitrate during infusion: a literature survey and practical recommendations.
    Remon JP; Bogaert MG
    Acta Clin Belg; 1983; 38(5):338-41. PubMed ID: 6419518
    [No Abstract]   [Full Text] [Related]  

  • 92. Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
    Natarajan D; Khurana TR; Karhade V; Nigam PD
    Am J Cardiol; 1988 Aug; 62(4):319-21. PubMed ID: 3135741
    [No Abstract]   [Full Text] [Related]  

  • 93. Plastic syringes and intravenous infusions.
    Roberts MS; Cossum PA; Kowaluk EA; Polack AE; Flukes WK
    Med J Aust; 1981 Nov; 2(11):580-1. PubMed ID: 6801447
    [No Abstract]   [Full Text] [Related]  

  • 94. Prolonged hemodynamic effect of furosemide in congestive heart failure.
    Brater DC; Chennavasin P; Dehmer GJ
    Am Heart J; 1984 Oct; 108(4 Pt 1):1031-2. PubMed ID: 6485981
    [No Abstract]   [Full Text] [Related]  

  • 95. Hypertensive crisis managed by computer controlled infusion of sodium nitroprusside: a model for the closed loop administration of short acting vasoactive agents.
    Hammond JJ; Kirkendall WM; Calfee RV
    Comput Biomed Res; 1979 Apr; 12(2):97-108. PubMed ID: 428218
    [No Abstract]   [Full Text] [Related]  

  • 96. Always prepare an i.v. admixture before labeling the container.
    Cohen MR
    Nursing; 1988 Mar; 18(3):10. PubMed ID: 3352968
    [No Abstract]   [Full Text] [Related]  

  • 97. Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure.
    Armstrong PW; Armstrong JA; Marks GS
    Am J Cardiol; 1980 Oct; 46(4):670-6. PubMed ID: 6774604
    [No Abstract]   [Full Text] [Related]  

  • 98. Dose limits to acute nitroprusside therapy challenged.
    Katz RL
    Anesthesiology; 1977 Oct; 47(4):395-6. PubMed ID: 900553
    [No Abstract]   [Full Text] [Related]  

  • 99. Dose limits to acute nitroprusside therapy challenged.
    Vesey C; Cole P
    Anesthesiology; 1978 Jul; 49(1):55-6. PubMed ID: 666047
    [No Abstract]   [Full Text] [Related]  

  • 100. Importance of symptoms in recognizing nitroprusside toxicity.
    Rieves RD
    South Med J; 1984 Aug; 77(8):1035-7. PubMed ID: 6431613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.